Testing effectiveness (Phase 2)Ended earlyNCT02847650
What this trial is testing
Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease
Who this might be right for
Parkinson Disease
Pfizer 57
Showing 20 of 0 results